Reinhard Fässler, M.D., discussed his research into cell adhesion during his recent Flexner Discovery Lecture. Fässler is the director of the Department of Molecular Medicine at the Max Planck Institute in Martinsried, Germany.

Lawrence Marnett, Ph.D., second from right, talks with three Vanderbilt scientists prior to their presentations during last week’s Flexner Discovery Lecture on cutting-edge research. The speakers were, from left, Mark Wallace, Ph.D., Laura Dugan, M.D., and Sachin Patel, M.D., Ph.D.

Reinhard Fässler, M.D., director of the Department of Molecular Medicine at the Max Planck Institute in Martinsried, Germany, will deliver the next Flexner Discovery Lecture on Nov. 10.

Three Vanderbilt University neuroscientists on the forefront of research in autism, addiction and Alzheimer’s disease will discuss their cutting-edge investigations during the next Flexner Discovery Lecture on Thursday, Nov. 3.

John Kappler, Ph.D., a pioneer in the study of autoimmune diseases at National Jewish Health in Denver, Colorado, visited with members of the family of the late Irwin Eskind, M.D., prior to delivering the Irwin Eskind Lecture in Biomedical Science at VUMC last week.

Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3.

Pediatric neurologist Elizabeth Engle, M.D., center, talks with Vanderbilt’s Christopher Williams, M.D., Ph.D., and Jennifer Pietenpol, Ph.D., after her recent Flexner Discovery Lecture.